A review of Cabenuva®, an antiretroviral agent for HIV.
The Canadian Breakpoint por Dr. Rupeena Purewal
T1 · E4
22 feb 2022
36:02
Notas del episodio
Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.
Palabras clave
cabenuva